Renal Autotransplantation and Extracorporeal Nephron-Sparing Surgery for De Novo Renal Cell Carcinoma in a Kidney Allograft. Issue 8 (August 2017)

• Record Type: Journal Article
• Authors: Ono, Shinichiro; Kenmochi, Takashi; Ito, Taihei; Aida, Naohiro; Otsuki, Kazunori; Akutsu, Naotake; Maruyama, Michihiro; Kusaka, Mamoru; Shiroki, Ryoichi; Hoshinaga, Kiyotaka
• Is Part Of: Transplantation direct. Volume 3:Issue 8(2017)
• Publication Date: 2017-08
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation -- Periodicals; 362.19795
• DOI: 10.1097/TXD.0000000000000714
• Languages: English
• ISSNs: 2373-8731

Abstract

Abstract : Abstract: De novo renal cell carcinoma (RCC) rarely occurs in kidney allografts; however, the risk of RCC in these patients is 100-fold that of the general healthy population. Although total nephrectomy has been the standard treatment for kidney allograft RCC, several authors have reported that early-stage RCC in kidney allografts was successfully treated with nephron-sparing surgery. We herein describe a new procedure involving renal autotransplantation and extracorporeal nephron-sparing surgery, which was performed to treat de novo RCC near the hilum of a transplanted kidney. In the 22 months since transplantation, the patient's renal function has been favorable, and no recurrence has been observed. In conclusion, renal autotransplantation is a feasible technique for the treatment of RCC in kidney allografts, especially RCC located near the hilum.